SALT LAKE CITY, Sept. 07, 2017 -- Kuali has released Kuali Protocols, a new solution to lighten the complex compliance management burden on research investigators, administrators, chairs, and reviewers.
|
|||
Developed in close partnership with higher education research institutions, Kuali Protocols provides a single solution for managing research protocols. Protocol creation and review are made easier with a comfortable and consistent interface, intuitive navigation, configurable forms, and smart reviewer tools. The cloud-based solution ensures the software is always up to date, without IT dependence.
“The University of Waterloo is pleased to be working with Kuali to bring an improved ethics system to our researchers. The enthusiasm and efficiency with which the team at Kuali tackles new challenges is exceptional. Kuali has proved to be a valuable and reliable partner, offering excellent service and quality,” says John Thompson, Associate Vice President, University Research.
Faculty spend nearly half of their active research time on administration rather than the research itself*, something Kuali wants to help change.
“Responsible researchers want to make an impact in discovering new knowledge and are committed to ensuring research is done in a safe ethical way,” said Trey Bean, General Manager, Kuali Research. “With Kuali Protocols, we are reducing the complexities and typical friction of compliance management so researchers can spend more time on the actual research and less time on paperwork.”
Kuali Protocols boasts inventive new features to help research administrators accomplish more and make an impact, including:
- The Kuali Form Designer enables easy configuration of any part of a protocol form without having to code or seek IT help. Admins can create the forms and fields to fit their specific needs.
- Field-level commenting and the ability to compare specific changes between protocol versions make the application, review, and post-approval processes easier for all involved — researchers, admins, and reviewers.
Support for IRB and IACUC is available today and support for other protocols is planned. To find out more about Kuali Research, Kuali Protocols, our commitment to open source, and how to become part of the dynamic Kuali Community, visit www.kuali.co/protocols.
*Rockwell S. The FDP Faculty Burden Survey. Research management review. 2009;16(2):29-44.
About Kuali
Kuali helps research offices reach their goals by simplifying administration and compliance, maximizing funding, and making more informed decisions. With thoughtfully-designed, open-source software delivered from the cloud, Kuali Research SaaS solutions span the full research lifecycle, including pre-award, post-award, COI and protocols. To learn more, visit www.kuali.co/research.
Trademark information: Kuali, the Kuali mark and logo, and Kuali product names are registered trademarks or trademarks of Kuali Foundation, Inc. in the United States and/or other countries. Other names are owned by other parties and are used with permission.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/12e5981f-6658-48d0-83d3-ca5e66e0ceeb
Laura Kvinge Kuali 7072979263 [email protected]


Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Italy Fines Apple €98.6 Million Over App Store Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 



